4d2s
From Proteopedia
(Difference between revisions)
(5 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
- | '''Unreleased structure''' | ||
- | + | ==Human TTK in complex with a Dyrk1B inhibitor== | |
+ | <StructureSection load='4d2s' size='340' side='right'caption='[[4d2s]], [[Resolution|resolution]] 2.50Å' scene=''> | ||
+ | == Structural highlights == | ||
+ | <table><tr><td colspan='2'>[[4d2s]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4D2S OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4D2S FirstGlance]. <br> | ||
+ | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.5Å</td></tr> | ||
+ | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=DYK:N-{2-METHOXY-4-[(1-METHYLPIPERIDIN-4-YL)OXY]PHENYL}-4-(1H-PYRROLO[2,3-C]PYRIDIN-3-YL)PYRIMIDIN-2-AMINE'>DYK</scene></td></tr> | ||
+ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4d2s FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4d2s OCA], [https://pdbe.org/4d2s PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4d2s RCSB], [https://www.ebi.ac.uk/pdbsum/4d2s PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4d2s ProSAT]</span></td></tr> | ||
+ | </table> | ||
+ | == Function == | ||
+ | [https://www.uniprot.org/uniprot/TTK_HUMAN TTK_HUMAN] Phosphorylates proteins on serine, threonine, and tyrosine. Probably associated with cell proliferation. Essential for chromosome alignment by enhancing AURKB activity (via direct CDCA8 phosphorylation) at the centromere, and for the mitotic checkpoint.<ref>PMID:18243099</ref> | ||
+ | <div style="background-color:#fffaf0;"> | ||
+ | == Publication Abstract from PubMed == | ||
+ | Potent and selective inhibitors of Dyrk1B kinase were developed to explore the hypothesis, based on siRNA studies, that Dyrk1B may be a resistance mechanism in cells undergoing a stress response. | ||
- | + | Discovery and Optimization of a Novel Series of Dyrk1B Kinase Inhibitors To Explore a MEK Resistance Hypothesis.,Kettle JG, Ballard P, Bardelle C, Cockerill M, Colclough N, Critchlow SE, Debreczeni J, Fairley G, Fillery S, Graham MA, Goodwin L, Guichard S, Hudson K, Ward RA, Whittaker D J Med Chem. 2015 Mar 26;58(6):2834-44. doi: 10.1021/acs.jmedchem.5b00098. Epub, 2015 Mar 12. PMID:25738750<ref>PMID:25738750</ref> | |
- | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
- | [[Category: | + | </div> |
- | [[Category: | + | <div class="pdbe-citations 4d2s" style="background-color:#fffaf0;"></div> |
- | [[Category: | + | |
- | [[Category: | + | ==See Also== |
- | [[Category: | + | *[[Dual specificity protein kinase 3D structures|Dual specificity protein kinase 3D structures]] |
- | [[Category: | + | == References == |
- | [[Category: | + | <references/> |
- | [[Category: | + | __TOC__ |
- | [[Category: | + | </StructureSection> |
- | [[Category: | + | [[Category: Homo sapiens]] |
- | [[Category: Goodwin | + | [[Category: Large Structures]] |
- | [[Category: | + | [[Category: Ballard P]] |
- | [[Category: | + | [[Category: Bardelle C]] |
- | [[Category: | + | [[Category: Butterworth S]] |
- | [[Category: | + | [[Category: Colclough N]] |
- | [[Category: | + | [[Category: Critchlow SE]] |
- | [[Category: | + | [[Category: Debreczeni JE]] |
- | [[Category: | + | [[Category: Fairley G]] |
+ | [[Category: Fillery S]] | ||
+ | [[Category: Goodwin L]] | ||
+ | [[Category: Graham MA]] | ||
+ | [[Category: Guichard S]] | ||
+ | [[Category: Hudson K]] | ||
+ | [[Category: Kettle JG]] | ||
+ | [[Category: Mahmood A]] | ||
+ | [[Category: Vincent J]] | ||
+ | [[Category: Ward RA]] | ||
+ | [[Category: Whittaker D]] |
Current revision
Human TTK in complex with a Dyrk1B inhibitor
|
Categories: Homo sapiens | Large Structures | Ballard P | Bardelle C | Butterworth S | Colclough N | Critchlow SE | Debreczeni JE | Fairley G | Fillery S | Goodwin L | Graham MA | Guichard S | Hudson K | Kettle JG | Mahmood A | Vincent J | Ward RA | Whittaker D